658 related articles for article (PubMed ID: 10697931)
1. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
[TBL] [Abstract][Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
3. Open trial of methotrexate as treatment for autoimmune hearing loss.
Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
[TBL] [Abstract][Full Text] [Related]
4. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of low dose intramuscular streptomycin for Menière's disease.
Shea JJ; Ge X; Orchik DJ
Am J Otol; 1994 Jul; 15(4):540-4. PubMed ID: 8588611
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
7. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
8. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
9. Alternobaric oxygen therapy in long-term treatment of Ménière's disease.
Fattori B; De Iaco G; Nacci A; Casani A; Ursino F
Undersea Hyperb Med; 2002; 29(4):260-70. PubMed ID: 12797667
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
Li CS; Lai JT
Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
[TBL] [Abstract][Full Text] [Related]
11. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
[TBL] [Abstract][Full Text] [Related]
12. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
14. Transtympanic steroids for Ménière's disease.
Herraiz C; Plaza G; Aparicio JM; Gallego I; Marcos S; Ruiz C
Otol Neurotol; 2010 Jan; 31(1):162-7. PubMed ID: 19924013
[TBL] [Abstract][Full Text] [Related]
15. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
Suryanarayanan R; Cook JA
J Laryngol Otol; 2004 Jul; 118(7):489-95. PubMed ID: 15318953
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate in the management of immune mediated cochleovesitibular disorders: clinical experience with 53 patients.
Salley LH; Grimm M; Sismanis A; Spencer RF; Wise CM
J Rheumatol; 2001 May; 28(5):1037-40. PubMed ID: 11361185
[TBL] [Abstract][Full Text] [Related]
19. Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
García Berrocal JR; Ramírez-Camacho R; Arellano B; Vargas JA
Laryngoscope; 2002 Feb; 112(2):304-9. PubMed ID: 11889388
[TBL] [Abstract][Full Text] [Related]
20. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
